![]() |
市场调查报告书
商品编码
1930066
全球脉搏血氧仪市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测(2026-2034)Pulse Oximeters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球脉搏血氧仪市场规模为24.6亿美元。在本报告涵盖的预测期内,预计该市场将在2026年成长至25.9亿美元,并在2034年达到40亿美元,2026年至2034年的年复合成长率(CAGR)为5.60%。北美地区在2025年占据市场主导地位,市场占有率达40.70%,这得益于其先进的医疗基础设施、患者监护技术的广泛应用以及主要製造商的强大实力。由于慢性呼吸系统疾病盛行率的上升以及家用医疗设备的日益普及,预计美国脉搏血氧仪市场将显着成长。
脉搏血氧仪是一种非侵入性医疗设备,用于监测血氧饱和度,这是检测低氧血症的关键指标。低氧血症若不及时诊断,可能导致严重的併发症,例如急性呼吸衰竭。气喘、慢性支气管炎、慢性阻塞性肺病(COPD)、急性呼吸窘迫症候群(ARDS)、充血性心臟衰竭和贫血等疾病显着提高了在医院和家庭医疗保健环境中进行血氧饱和度监测的临床重要性。
市场动态
心血管和呼吸系统疾病盛行率的不断上升仍然是市场成长的主要驱动力。心臟衰竭和慢性呼吸系统疾病,尤其是在老年族群中,显着促进了2025年脉搏血氧仪的普及。老年患者发生氧饱和度下降的风险更高,这导致脉搏血氧仪在家庭持续监测中的应用日益广泛。
在新冠肺炎疫情期间,脉搏血氧仪的需求激增,因为它们成为监测感染患者的必需品。然而,从2022年和2023年开始,由于紧急需求下降,市场经历了暂时的下滑。儘管如此,慢性病管理和预防性筛检措施仍将持续支撑市场的长期成长。
市场趋势
市场参与者致力于併购和产品创新,以增强其竞争地位。 Masimo 和 Medtronic 等公司不断拓展其产品线,推出先进的、获得 FDA 批准的血氧饱和度测量解决方案。指尖式和无线设备的推出提高了患者的便利性,扩大了其在家庭医疗保健和门诊环境中的应用。
同时,监管机构对新生儿先天性心臟病筛检的重视,以及在麻醉和手术过程中日益使用血氧仪,都有助于维持医疗机构的稳定需求。
市场成长驱动因素
慢性呼吸系统疾病(如 COPD、气喘、睡眠呼吸中止症和肺癌)盛行率的不断上升,持续推动市场扩张。氧饱和度监测在诊断和疾病管理中发挥非常重要的作用,尤其是在医院环境中。此外,早产儿数量的增加也推动了对新生儿和儿童脉搏血氧仪的需求。
政府指南强制要求在重症监护和手术环境中进行氧饱和度监测,这进一步促进了产品的普及。一些已开发国家和发展中国家已经实施了新生儿脉搏血氧饱和度筛检计画,提高了其在医疗机构的使用率。
限制因子
儘管应用广泛,但准确性方面的限制制约了市场成长。血液循环不良、皮肤色素沉着、指甲油和运动伪影等因素都会影响测量准确性。研究表明,肤色较深的患者测量结果存在不一致的情况,这引起了监管机构的关注,并促使美国食品药物管理局(FDA)更新了相关指南。这些问题促使製造商投资改进感测器技术,但确保普遍可靠性仍然是个挑战。
细分市场分析
依产品类型划分:
受慢性阻塞性肺病(COPD)和气喘住院人数不断增加的推动,台式血氧仪将在2026年占据 40.54%的市场占有率。指尖式血氧仪因其便携性和在家庭医疗保健环境中的广泛应用,预计将快速成长。
依技术划分:
传统血氧仪将在2026年占据 79.15%的市场占有率,反映出医院对有线监测系统的强劲需求。智慧血氧仪因其无线连接和远端患者监测功能而日益普及。
依年龄层划分:
受慢性呼吸系统疾病和心血管疾病高发生率的推动,成年人将在2026年占总需求的92.28%。由于气喘发病率上升和新生儿筛检计画的广泛应用,儿科应用不断成长。
依最终使用者划分:
受持续病患监测需求的驱动,医院和门诊手术中心预计在2026年将占据62.93%的市场占有率。由于人们意识的提高和设备的普及,家庭医疗保健成为一个高成长领域。
区域考察
北美预计将保持领先地位,在先进的监测技术和强大的製造商实力推动下,2025年市场规模将达到10亿美元,2026年将达到10.5亿美元。欧洲将紧随其后,这主要得益于强制性新生儿筛检计画和不断扩大的医疗基础设施。亚太地区预计将在2034年之前实现最快成长,这主要得益于医疗保健投资的增加、疾病意识的提高以及中国、印度和日本医院容量的扩大。
主要公司
市场上的主要公司包括GE HealthCare、Masimo、Medtronic、Koninklijke Philips N.V.、NIHON KOHDEN CORPORATION、Nonin。这些公司致力于创新、获得监管部门批准以及建立全球分销网路,以保持其竞争优势。
分析
本报告对脉搏血氧仪市场进行了全面分析,涵盖2025年、2026年和2034年的市场规模,以及市场趋势、细分、区域展望、竞争格局和新冠疫情的影响。报告还深入分析了技术进步、监管环境以及策略性举措(例如併购和新产品发布),这些因素都将影响市场动态。
The global pulse oximeter market was valued at USD 2.46 billion in 2025. As per the report timeline, the market is projected to grow to USD 2.59 billion in 2026 and further reach USD 4.00 billion by 2034, registering a CAGR of 5.60% during the 2026-2034 forecast period. North America dominated the market with a 40.70% share in 2025, supported by advanced healthcare infrastructure, high adoption of patient monitoring technologies, and a strong presence of key manufacturers. The U.S. pulse oximeters market is expected to show notable expansion, supported by the rising prevalence of chronic respiratory disorders and the increasing use of home healthcare devices.
Pulse oximeters are non-invasive medical devices used to monitor blood oxygen saturation levels, a critical parameter for detecting hypoxemia. Hypoxemia, if left undiagnosed, can lead to severe complications such as acute respiratory failure. Conditions including asthma, chronic bronchitis, COPD, ARDS, congestive heart failure, and anemia have significantly increased the clinical importance of oxygen saturation monitoring in both hospital and homecare settings.
MARKET DYNAMICS
The increasing prevalence of cardiovascular and respiratory disorders remains a key driver of market growth. In 2025, heart failure and chronic respiratory diseases contributed substantially to device adoption, particularly among the aging population. Elderly patients are more susceptible to oxygen desaturation, which has increased the use of pulse oximeters for continuous and home-based monitoring.
Demand surged during the COVID-19 pandemic as pulse oximeters became essential for monitoring infected patients. However, after 2022 and 2023, the market experienced a temporary decline due to reduced emergency demand. Despite this, long-term growth remains supported by chronic disease management and preventive screening initiatives.
MARKET TRENDS
Market players are increasingly focusing on mergers, acquisitions, and product innovation to strengthen their competitive position. Companies such as Masimo and Medtronic have continued to expand their portfolios with advanced and FDA-approved oximetry solutions. The introduction of fingertip and wireless devices has improved patient convenience and expanded usage in home healthcare and ambulatory settings.
In parallel, regulatory emphasis on newborn screening for congenital heart defects and increased use of oximeters during anesthesia and surgery have contributed to stable institutional demand.
MARKET GROWTH FACTORS
The rising burden of chronic respiratory diseases such as COPD, asthma, sleep apnea, and lung cancer continues to support market expansion. Oxygen saturation monitoring plays a critical role in diagnosis and disease management, particularly in hospital environments. Additionally, the increasing number of preterm births has boosted demand for neonatal and pediatric pulse oximeters.
Government guidelines mandating oxygen monitoring in critical care and surgical settings have further strengthened product adoption. Pulse oximetry screening programs for newborns have been implemented across several developed and developing countries, increasing institutional usage.
RESTRAINING FACTORS
Despite widespread adoption, limitations related to accuracy have restrained market growth. Factors such as poor circulation, skin pigmentation, nail polish, and motion artifacts can affect reading precision. Studies have highlighted discrepancies in readings among patients with darker skin tones, leading to regulatory scrutiny and updated FDA guidelines. These concerns have encouraged manufacturers to invest in improved sensor technologies but remain a challenge for universal reliability.
SEGMENTATION ANALYSIS
By Product Type:
Tabletop oximeters dominated the market with a 40.54% share in 2026, driven by high hospital admissions for COPD and asthma. Fingertip oximeters are expected to grow rapidly due to their portability and increased use in homecare environments.
By Technology:
Conventional oximeters accounted for 79.15% of the market in 2026, reflecting strong demand for wired monitoring systems in hospitals. Smart oximeters are gaining traction due to wireless connectivity and remote patient monitoring capabilities.
By Age Group:
Adults represented 92.28% of total demand in 2026, supported by higher prevalence of chronic respiratory and cardiovascular disorders. Pediatric adoption is increasing due to rising asthma incidence and neonatal screening programs.
By End User:
Hospitals and ambulatory surgical centers held a 62.93% market share in 2026, supported by continuous patient monitoring needs. Home healthcare is emerging as a high-growth segment due to increasing awareness and device availability.
REGIONAL INSIGHTS
North America led the market with a valuation of USD 1.00 billion in 2025 and USD 1.05 billion in 2026, driven by advanced monitoring technologies and strong manufacturer presence. Europe followed, supported by mandatory newborn screening programs and healthcare infrastructure expansion. Asia Pacific is expected to record the fastest growth through 2034, fueled by rising healthcare investments, increasing disease awareness, and expanding hospital capacity in China, India, and Japan.
KEY INDUSTRY PLAYERS
Leading companies operating in the market include GE HealthCare, Masimo, Medtronic, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, and Nonin. These players focus on innovation, regulatory approvals, and global distribution to maintain competitiveness.
REPORT COVERAGE
The report provides a comprehensive analysis of the pulse oximeter market, covering market size for 2025, 2026, and 2034, along with trends, segmentation, regional outlook, competitive landscape, and the impact of COVID-19. It includes insights into technological advancements, regulatory developments, and strategic initiatives such as mergers, acquisitions, and new product launches influencing market dynamics.
CONCLUSION
The global pulse oximeter market shows steady and sustained expansion across the report period, supported by the growing burden of chronic respiratory and cardiovascular diseases and the increasing need for continuous patient monitoring. With the market valued at USD 2.46 billion in 2025, rising to USD 2.59 billion in 2026, and projected to reach USD 4.00 billion by 2034, growth is primarily driven by hospital-based demand and the rising adoption of home healthcare monitoring devices. The dominance of North America with a 40.70% market share in 2025 reflects strong healthcare infrastructure and early adoption of advanced monitoring technologies. Continued technological innovation, regulatory support for screening and monitoring, and expanding awareness of early hypoxemia detection are expected to sustain market momentum throughout the forecast period.
Segmentation By Product Type
By Technology
By Age Group
By End-user
By Region